Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT00247858
Brief Summary:
To analyze microbiological data from MRSA samples obtained through the emergency department from 2001-2005. There is a strong clinical suspicion that we are now seeing an outbreak of a new strain of MRSA and we plan to better characterize the Vancouver population and complete a chart review to assess specific associated factors.
Detailed Description:
Pulse field gel electrophoresis, SCC mec typing, antibiotic susceptibilities, presence of the Panton-Valentine Leukocidin gene will be carried out. Clinical manifestations and associated factors will be assessed via chart review. These include: recent antibiotic use, recent hospitalization, IV drug use, HIV status, number of co-morbidities identified, presence of soft tissue abscess, post operative status, presence of bacteremia, residence in Vancouver's downtown eastside (an area of particularly low socioeconomic status).
Study:
NCT00247858
Study Brief:
Protocol Section:
NCT00247858